Investigational new drugAndrogen Modulator
Compound 61948
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061948
Risk Class
HIGH
Last Audit
Oct 21, 2108
Research Abstract
Androgen Modulator candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Compound 61948 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for oncology adjuvant and inflammation control.
The dossier currently sits in investigational new drug with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061948 with updates logged 2108-10-21.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Oncology adjuvantInflammation control
Nomenclature
CX-61948Androgen Modulator Program 61948
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061948
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61948